期刊文献+

肝癌转移相关分子的血清蛋白质组学分析 被引量:5

Serum proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma
暂未订购
导出
摘要 目的应用差异蛋白质组学方法筛查血清中与肝癌转移相关的蛋白质分子。方法收集具有相同疾病背景原发性肝癌(肝内转移和未转移)患者以及正常人的血清(每组各20例),经过去高丰度蛋白预处理后,进行双向电泳(2-DE)分析,筛选出肝内转移肝癌与未转移肝癌相比较有显著性差异的蛋白质斑点,进行MALDI-TOF/TOF质谱鉴定;使用Western blotting验证蛋白质组分析的结果。结果对3组血清的双向电泳图谱分析,与正常人和未转移肝癌患者的血清相比,在肝内转移肝癌血清中共筛选出12个差异大于2倍的蛋白质斑点,MALDI-TOF/TOF成功鉴定出3个表达下调的蛋白质[包括Inter-alpha(globulin)inhibitor H4、Complement factor H-related protein1precursor(FHR-1)、apolipoprotein E]和一个上调蛋白(Cytokeratin9,CK9)。Western blotting对所有样本血清中的CK9进行了检测,结果与蛋白质组分析结果相一致。结论肝癌的转移与多种蛋白表达改变相关,其中CK9的高表达可能与肝癌的转移有关,可能作为肝癌转移相关的潜在血清标志物。 Objective To screen the serum proteins associated with the metastasis of hepatocellular carcinoma (HCC) using a comparative proteomic approach. Methods The serum samples of HCC patients with the same disease background were divided into metastatic (n=20) and non-metastatic (n=20) groups. The proteins extracted from the patients and 20 normal subjects, after depletion of the highly abundant proteins, underwent two-dimensional gel electrophoresis (2-DE). Comparative analyses of the 2-DE protein patterns between the 3 groups were conducted using a computerized image analysis system. The proteins with statistically significant differential expression between the metastatic and non-metastatic patients were identified by mass spectrometry. Western blotting was performed to examine the differential expression of the candidate proteins. Results Four protein spots were identified by mass spectrometry among the 12 differentially expressed protein spots in the serum samples of HCC patients with intrahepatic metastasis, and confirmed by searching in MASCOT database. Of the 4 proteins, cytokeratin 9 (CK9) was up-regulated by 2 folds, and inter-alpha (globulin) inhibitor H4, complement factor H-related protein 1 precursor (FHR-1), and apolipoprotein E were down-regulated by 2 folds. CK9 was found to be specifically over-expressed in the metastatic group in comparison with the non-metastatic group, as confirmed by Western blotting. Conclusion The metastasis of HCC might be correlated to the specific variation of protein expression profiles. The overexpression of CK9 may play a crucial role in HCC metastasis, and can be used as a potential serum marker for predicting HCC metastasis.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第9期1775-1778,共4页 Journal of Southern Medical University
基金 国家重点基础研究发展计划(973计划)(2009CB522404) 国家十一五科技重大专项课题(2008ZX10209) 2007-2009年度卫生部部属(管)医院临床学科重点项目 广东省科技计划项目重大专项(2007A032000001) 中国博士后科学基金(20070420794)
关键词 肝细胞癌 转移 蛋白质组学 血清 hepatocellular carcinoma metastasis proteomics serum
  • 相关文献

参考文献8

  • 1Anderson NL, Polanski M, Pieper R, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources [J ]. Mol Cell Proteomics, 2004, 3(4): 311-26.
  • 2Minata M, Nishida N, Komeda T, et al. Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma [ J ]. J Gastroenterol Hepatol, 2001, 16(4): 445-51.
  • 3Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells[J]. Cell, 1982, 31(1): 11-24.
  • 4Dai Z, Liu YK, Cui JF, et al. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis [J ]. Proteomics, 2006, 6(21): 5857-67.
  • 5Ding S J, Li Y, Tan YX, et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis [ J ]. Mol Cell Proteomics, 2004, 3(1): 73-81.
  • 6Li Y, Tang ZY, Tian B, et al. Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients [ J ]. J Cancer Res Clin Oncol, 2006, 132(8): 515-20.
  • 7Li M, Yang LJ, Hua HK, et al. Keratin-9 gene mutation in epidermolytic palmoplantar keratoderma combined with knuckle pads in a large Chinese family[J]. Clin Exp Dermatol, 2009, 34(1): 26-8.
  • 8Sloan DD, Nicholson B, Urquidi V, et al. Detection of differentially expressed genes in an isogenic breast metastasis model using RNA arbitrarily primed-polymerase chain reaction coupled with array hybridization (RAP-array) [ J]. Am J Pathol, 2004, 164(1): 315-23.

同被引文献44

  • 1Jiang Long,Zhen-Wei Lang,Hua-Guang Wang,Tai-Ling Wang,Bao-En Wang and Si-Qi Liu Liver Research Center,Beijing Friendship Hospital, Capital Medical University,Beijing 100050,China,Department of Hepatology,Department of Pathology, Beijing Youan Hospital,Capital Medical University,Beijing 100069,China,Department of Pharmaceutical Affairs,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China,Department of Pathology,China-Japan Friendship Hospital,Beijing 100029,China,Beijing Genomics Institute,Chinese Academy of Science,Beijing Airport Industrial Zone B-6,Shunyi,Beijing 101300,China.Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected smal hepatocel ular carcinomas[J].Hepatobiliary & Pancreatic Diseases International,2010,9(3):296-305. 被引量:21
  • 2刘博,黄志强,周宁新,肖雪媛,刘丹慧,何大澄.肝癌细胞系SMMC7721蛋白质组学初步分析[J].中华实验外科杂志,2004,21(12):1439-1440. 被引量:10
  • 3叶丽虹,秦宵然,张晓东,齐众,钱令嘉,侯志波,王洪辉,徐少峰.原肌球蛋白、波形纤维蛋白和热休克蛋白70在肝癌转移亚细胞中表达上调[J].中国生物化学与分子生物学报,2005,21(2):244-249. 被引量:14
  • 4宁钧宇,由江峰,裴斐,王洁良,崔湘霖,郑杰.G3BP单克隆抗体制备及G3BP在肿瘤组织中表达的检测[J].中华病理学杂志,2005,34(4):215-219. 被引量:16
  • 5唐平章,吴雪溪.下咽癌外科[M]/屠规益.现代头颈肿瘤外科学.北京:科学出版社,2004:593-612.
  • 6Gourin CG, Ten-is DJ. Carcinoma of the hypopharynx [J]. Surg Oncol Clin N Am, 2004, 13(1): 81-98.
  • 7Lee KJ. Essential otolaryngology: Head and neck surgery [M] //Ninth edition. New York: Mcgraw-hill Professional Publishing, 2008: 676-707.
  • 8Sasaki CT, Jassin B. Cancer of the pharynx and larynx[J]. Am J Med, 2001, 111 (Suppl 8A): 118S-123S.
  • 9Gourin CG, Xia ZS, Han Y, et al. Serum protein profile analysis in patients with head and neck squamous cell carcinoma [J]. Arch Otolaryngol Head Neck Surg, 2006, 132(4): 390-97.
  • 10Gourin CG, Moretz WH 3rd, Weinberger PM, et al. Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma [J]. Arch Otolaryngol Head Neck Surg, 2007, 133(11): 1125-30.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部